78 results
424B3
LGVN
Longeveron Inc - Ordinary Shares
22 May 24
Prospectus supplement
5:28pm
approvals, subsequent commercialization, and broad use by the healthcare community.
In November of 2023, Longeveron received notice from the World Health … -expectancy by over a decade. This has placed tremendous strain on healthcare systems in the management of aging-related ailments and presents
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
10 May 24
Longeveron Announces Board of Directors Planned Transitions
4:30pm
healthcare investment banker at William Blair, Truist, and Oppenheimer and Company, also has been nominated as a candidate for the Board, subject … of Directors has also nominated Roger Hajjar, MD, former head of R&D at Ring Therapeutics, and Neha Motwani, a former senior healthcare investment banker
8-K
EX-99.1
5hj19f
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
8-K
EX-99.2
li8aw9o
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
424B4
ger7 lkcs
17 Apr 24
Prospectus supplement with pricing info
5:07pm
8-K
EX-99.2
0i700
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
8-K
EX-99.1
7hvtwwck
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
424B4
d9wqg6oc23orme gb
10 Apr 24
Prospectus supplement with pricing info
7:48am
FWP
9pa qw0uoqkbc7p
8 Apr 24
Free writing prospectus
8:45am
8-K
EX-99.1
zxat fbhag
19 Mar 24
Longeveron Announces 1-for-10 Reverse Stock Split
4:01pm